Digital therapeutics in the clinic

Author:

Phan Philana1,Mitragotri Samir23ORCID,Zhao Zongmin1ORCID

Affiliation:

1. Department of Pharmaceutical Sciences, College of Pharmacy University of Illinois Chicago Chicago Illinois USA

2. John A. Paulson School of Engineering and Applied Sciences Harvard University Cambridge Massachusetts USA

3. Wyss Institute for Biologically Inspired Engineering at Harvard University Boston Massachusetts USA

Abstract

AbstractDigital therapeutics are emerging as a new form of therapeutic interventions. Unlike conventional therapeutics, digital therapeutics deliver interventions directly to patients using an evidence‐based, clinically evaluated software to treat, manage, or prevent diseases. Digital therapeutics manifest in diverse forms such as web‐based applications, mobile applications on smart devices, virtual reality, and video games. As its own product category for FDA approval, digital therapeutics can function as stand‐alone treatments or in combination with conventional therapeutics to improve adherence and/or efficacy. Here, we review the clinical landscape of digital therapeutics. We summarize FDA‐approved products and their clinical use, overview >300 ongoing clinical trials, and discuss challenges for their clinical translation and strategies to overcome the same.

Publisher

Wiley

Subject

Pharmaceutical Science,Biomedical Engineering,Biotechnology

Reference105 articles.

1. Understanding DTx. Accessed January 13 2023.https://dtxalliance.org/understanding-dtx/

2. Diabetes Digital App Technology: Benefits, Challenges, and Recommendations. A Consensus Report by the European Association for the Study of Diabetes (EASD) and the American Diabetes Association (ADA) Diabetes Technology Working Group

3. The diagnostic and triage accuracy of digital and online symptom checker tools: a systematic review

4. FDA.FDA launches the digital health center of excellence. 2020. FDA.gov.

5. FDA.Digital Health Software Precertification (Pre‐Cert) Pilot Program.2022Accessed September 13 2022https://www.fda.gov/medical-devices/digital-health-center-excellence/digital-health-software-precertification-pre-cert-pilot-program

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3